The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study

K. B. Miller, K. Kyungmann, F. S. Morrison, J. N. Winter, J. M. Bennett, R. S. Neiman, D. R. Head, P. A. Cassileth, M. J. O'Connell

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study'. Together they form a unique fingerprint.